๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

395 SURVIVAL OF PATIENTS RECEIVING YTTRIUM-90 MICROSPHERES VS CHEMOEMBOLIZATION FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA

โœ Scribed by L.E. Moreno-Luna; R. Paz-Fumagalli; D.M. Harnois; P.C. de Groen; K.N. Lazaridis; K.V.N. Menon; N.F. La Russo; S.R. Alberts; G.J. Gores; T.M. Therneau; G.A. Wiseman; J.C. Andrews; L.R. Roberts

Book ID
117376321
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
55 KB
Volume
48
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Hepatic arterial 90Yttrium glass microsp
Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: Interim safety and survival data on 65 patients
โœ Brian I. Carr ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 129 KB

Hepatocellular carcinoma (HCC) generally arises in a cirrhotic liver and, in most cases, is multifocal and bilobar. Although trans-hepatic artery chemoembolization (TACE) can be highly affective in shrinking tumors, it is limited by virtue of the damage that it can cause to the liver that is already

Use of yttrium-90 microspheres (TheraSph
Use of yttrium-90 microspheres (TheraSphereยฎ) in a patient with unresectable hepatocellular carcinoma leading to liver transplantation: A case report
โœ Laura M. Kulik; Mary F. Mulcahy; Russell D. Hunter; Albert A. Nemcek Jr.; Michae ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 209 KB

Prior to therapy, model for end stage liver disease (MELD) scoring, diagnostic imaging and tumor staging were performed in a patient with T3 HCC. The patient received an orthotopic liver transplant (OLT) 42 days after treatment. The explant specimen showed complete necrosis of the target tumor. Foll